Finance

Beta
Lists
300558:SHE
Betta Pharmaceuticals Co Ltd
CNÂ¥48.33
-5.64%
(-2.89) 1D
Jun 2, 3:04:19 PM GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 300558...
Open
CNÂ¥50.64
High
CNÂ¥50.68
Low
CNÂ¥47.57
Mkt. cap
21.55B
Avg. vol.
13.27M
Volume
15.50M
P/E ratio
46.11
52-wk high
CNÂ¥79.80
52-wk low
CNÂ¥40.10
EPS
CNÂ¥1.05
Shares outstanding
420.73M
No. of employees
2K
Open
CNÂ¥50.64
High
CNÂ¥50.68
Low
CNÂ¥47.57
Mkt. cap
21.55B
Avg. vol.
13.27M
Volume
15.50M
P/E ratio
46.11
52-wk high
CNÂ¥79.80
52-wk low
CNÂ¥40.10
EPS
CNÂ¥1.05
Shares outstanding
420.73M
No. of employees
2K
News stories
From sources across the web
About Betta Pharmaceuticals Co Ltd
CEO-
Employees1.78K
FoundedJan 7, 2003
Headquarters-
SectorPharmaceutical industry
Websitebettapharma.com
Previous reportsAll values in CNY
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in CNY
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
813.86M
985.93M
892.00M
1.04B
Cost of goods sold
154.03M
208.48M
204.34M
217.50M
Cost of revenue
154.03M
208.48M
204.34M
217.50M
Research and development expenses
141.36M
118.31M
137.90M
97.44M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
441.20M
447.07M
477.36M
422.85M
Operating expense
590.90M
578.16M
625.07M
526.01M
Total operating expenses
744.93M
786.65M
829.41M
743.50M
Operating income
68.93M
199.28M
62.58M
296.33M
Other non operating income
1.60M
-8.80M
6.81M
-10.30M
EBT including unusual items
64.66M
203.76M
22.79M
282.47M
EBT excluding unusual items
49.15M
181.48M
38.51M
268.61M
Income tax expense
29.42M
31.46M
39.59M
51.31M
Effective tax rate
45.50%
15.44%
173.71%
18.16%
Other operating expenses
8.19M
13.08M
9.32M
6.34M
Net income
39.81M
177.04M
-11.60M
235.92M
Net profit margin
4.89%
17.96%
-1.30%
22.69%
Earnings per share
-
-
-
-
Interest and investment income
1.46M
862.68K
369.02K
564.57K
Interest expense
-17.24M
-18.62M
-18.62M
-17.98M
Net interest expenses
-15.79M
-17.76M
-18.25M
-17.41M
Depreciation and amortization charges
-
-
-
-
EBITDA
203.72M
291.32M
199.56M
433.31M
Gain or loss from assets sale
-72.94K
72.94K
-377.65K
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer